Hangzhou Tigermed Consulting Co., Ltd. (stock code: 03347 on The Stock Exchange of Hong Kong; 300347 on the Shenzhen Stock Exchange) published its monthly return on movements in securities for the period ended 31 October 2025. Total authorised share capital remained at RMB 861,026,050, comprising both A and H shares with no changes from the previous month.

As of 31 October 2025, the company’s issued A shares stood at 732,017,470, while 5,883,780 A shares were held as treasury shares, leaving the total number of A shares unchanged at 737,901,250. The H-share capital also remained stable at 123,124,800 issued shares. No share options, warrants, or convertible securities were outstanding, and no newly issued or repurchased shares were reported during October 2025.

The announcement noted that between May 2024 and February 2025, a total of 9,806,300 A shares were repurchased and held as treasury shares. Of these, 3,922,520 treasury shares were cancelled on 29 May 2025, resulting in the current treasury balance of 5,883,780 A shares at the end of October 2025. No other movements in issued shares or treasury shares were reported for the current period.